Journal of Antimicrobial Chemotherapy (2002) 50, 39-44
© 2002 The British Society for Antimicrobial Chemotherapy
Supplement |
Importance of dose and duration of ß-lactam therapy in nasopharyngeal colonization with resistant pneumococci
Department of Medicine, Hospital Mútua de Terrassa, Pl. Dr Robert 5, University of Barcelona, 08221 Terrassa, Barcelona, Spain
Abstract
Antibiotic use greatly influences the nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae and is considered to be one of the most important risk factors for carriage of such organisms. Several studies have shown a reduction in the prevalence of resistant strains following reduced antibiotic consumption. This indicates that it may be possible to reduce resistance rates by changing prescribing patterns. Studies suggest that antibiotics present at low levels tend to select strains with low-level penicillin resistance, that intermediate antibiotic levels may pose the danger of selection of pneumococci with high-level penicillin resistance and that attainment of high levels of antibiotics may reduce the selective pressure for penicillin resistance. High-dose ß-lactam (amoxicillin) therapy has been shown to reduce the selection of resistant pneumococci in the nasopharynx. Likewise, short-course antibiotic therapy has reduced colonization by resistant strains. Finally, the effect of the antibiotic appears to differ according to the ß-lactam prescribed. Studies suggest that selection by cephalosporins occurs at higher frequencies than that by amoxicillin; this may be explained by the reduced activity of cephalosporins against penicillin-resistant S. pneumoniae.
Footnotes
* Corresponding author. Tel: +34-93-736-50-50; Fax: +34-93-736-50-37; E-mail: jagarau{at}terra.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Farrell, J. Shackcloth, K. A. Barbadora, and M. D. Green Streptococcus pyogenes Isolates with High-Level Macrolide Resistance and Reduced Susceptibility to Telithromycin Associated with 23S rRNA Mutations Antimicrob. Agents Chemother., February 1, 2006; 50(2): 817 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rantala, S. Huikko, P. Huovinen, J. Jalava, and the Finnish Study Group for Antimicrobial Resistan Prevalence and Molecular Genetics of Macrolide Resistance among Streptococcus pneumoniae Isolates Collected in Finland in 2002 Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4180 - 4184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Green, C. Allen, J. Bradley, B. Dashefsky, J. R. Gilsdorf, M. J. Marcon, G. E. Schutze, C. Smith, E. Walter, J. M. Martin, et al. In Vitro Activity of Telithromycin against Macrolide-Susceptible and Macrolide-Resistant Pharyngeal Isolates of Group A Streptococci in the United States Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2487 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Abbanat, G. Webb, B. Foleno, Y. Li, M. Macielag, D. Montenegro, E. Wira, and K. Bush In Vitro Activities of Novel 2-Fluoro-Naphthyridine-Containing Ketolides Antimicrob. Agents Chemother., January 1, 2005; 49(1): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Okitsu, S. Kaieda, H. Yano, R. Nakano, Y. Hosaka, R. Okamoto, T. Kobayashi, and M. Inoue Characterization of ermB Gene Transposition by Tn1545 and Tn917 in Macrolide-Resistant Streptococcus pneumoniae Isolates J. Clin. Microbiol., January 1, 2005; 43(1): 168 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Desjardins, K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results J. Clin. Microbiol., December 1, 2004; 42(12): 5620 - 5623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Brown, D. J. Farrell, and I. Morrissey Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study J. Clin. Microbiol., November 1, 2004; 42(11): 4980 - 4987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Farrell, S G Jenkins, and R R Reinert Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators J. Med. Microbiol., November 1, 2004; 53(11): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Novotny, L. Jakobsen, N. M. Andersen, J. Poehlsgaard, and S. Douthwaite Ketolide Antimicrobial Activity Persists after Disruption of Interactions with Domain II of 23S rRNA Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3677 - 3683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell, I. Morrissey, S. Bakker, S. Buckridge, and D. Felmingham In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against Streptococcus pneumoniae with Macrolide Resistance Due to Ribosomal Mutations Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3169 - 3171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kresken, B. Henrichfreise, S. Bagel, J. Brauers, and B. Wiedemann High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3193 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Song, S.-I. Jung, K. S. Ko, N. Y. Kim, J. S. Son, H.-H. Chang, H. K. Ki, W. S. Oh, J. Y. Suh, K. R. Peck, et al. High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study) Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2101 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell and D. Felmingham Activities of Telithromycin against 13,874 Streptococcus pneumoniae Isolates Collected between 1999 and 2003 Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1882 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell, I. Morrissey, S. Bakker, L. Morris, S. Buckridge, and D. Felmingham Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance J. Clin. Microbiol., February 1, 2004; 42(2): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Neeleman, C. H. W. Klaassen, H. A. de Valk, M. T. de Ruiter, and J. W. Mouton Amplified Fragment Length Polymorphism Fingerprinting Is an Effective Technique To Distinguish Streptococcus pneumoniae from Other Streptococci and an Efficient Alternative to Pulsed-Field Gel Electrophoresis for Molecular Typing of Pneumococci J. Clin. Microbiol., January 1, 2004; 42(1): 369 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Waites, K. E. Jones, K. H. Kim, S. A. Moser, C. N. Johnson, S. K. Hollingshead, E.-S. Kang, K. S. Hong, and W. H. Benjamin Jr. Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea J. Clin. Microbiol., December 1, 2003; 41(12): 5787 - 5791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bingen, C. Doit, C. Loukil, N. Brahimi, P. Bidet, D. Deforche, and P. Geslin Activity of Telithromycin against Penicillin-Resistant Streptococcus pneumoniae Isolates Recovered from French Children with Invasive and Noninvasive Infections Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2345 - 2347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell, S. Douthwaite, I. Morrissey, S. Bakker, J. Poehlsgaard, L. Jakobsen, and D. Felmingham Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1777 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Van Bambeke, Y. Glupczynski, P. Plesiat, J. C. Pechere, and P. M. Tulkens Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy J. Antimicrob. Chemother., May 1, 2003; 51(5): 1055 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
I. Morrissey, D. J. Farrell, S. Bakker, S. Buckridge, and D. Felmingham Molecular Characterization and Antimicrobial Susceptibility of Fluoroquinolone-Resistant or -Susceptible Streptococcus pneumoniae from Hong Kong Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1433 - 1435. [Abstract] [Full Text] [PDF]
|
|